Global Glucokinase 麻豆原创 Research Report 2023

Publication ID:

PB503239275

Publication Date:

March 23, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

Highlights
The global Glucokinase market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Glucokinase is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Glucokinase is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucokinase.
The Glucokinase market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glucokinase market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp
Segment by Type
LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others
Segment by Application
Metabolic Disorder
Obesity
Diabetes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Glucokinase 麻豆原创 Overview
1.1 Product Overview and Scope of Glucokinase
1.2 Glucokinase Segment by Type
1.2.1 Global Glucokinase 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 LY-2608204
1.2.3 Sinogliatin
1.2.4 AM-9514
1.2.5 TMG-123
1.2.6 TTP-399
1.2.7 Others
1.3 Glucokinase Segment by Application
1.3.1 Global Glucokinase 麻豆原创 Value by Application: (2023-2029)
1.3.2 Metabolic Disorder
1.3.3 Obesity
1.3.4 Diabetes
1.3.5 Others
1.4 Global Glucokinase 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Glucokinase Revenue 2018-2029
1.4.2 Global Glucokinase Sales 2018-2029
1.4.3 Global Glucokinase 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glucokinase 麻豆原创 Competition by Manufacturers
2.1 Global Glucokinase Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Glucokinase Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Glucokinase Average Price by Manufacturers (2018-2023)
2.4 Global Glucokinase Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glucokinase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucokinase, Product Type & Application
2.7 Glucokinase 麻豆原创 Competitive Situation and Trends
2.7.1 Glucokinase 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucokinase Players 麻豆原创 Share by Revenue
2.7.3 Global Glucokinase 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucokinase Retrospective 麻豆原创 Scenario by Region
3.1 Global Glucokinase 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glucokinase Global Glucokinase Sales by Region: 2018-2029
3.2.1 Global Glucokinase Sales by Region: 2018-2023
3.2.2 Global Glucokinase Sales by Region: 2024-2029
3.3 Global Glucokinase Global Glucokinase Revenue by Region: 2018-2029
3.3.1 Global Glucokinase Revenue by Region: 2018-2023
3.3.2 Global Glucokinase Revenue by Region: 2024-2029
3.4 North America Glucokinase 麻豆原创 Facts & Figures by Country
3.4.1 North America Glucokinase 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glucokinase Sales by Country (2018-2029)
3.4.3 North America Glucokinase Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucokinase 麻豆原创 Facts & Figures by Country
3.5.1 Europe Glucokinase 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glucokinase Sales by Country (2018-2029)
3.5.3 Europe Glucokinase Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucokinase 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Glucokinase 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glucokinase Sales by Country (2018-2029)
3.6.3 Asia Pacific Glucokinase Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glucokinase 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Glucokinase 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glucokinase Sales by Country (2018-2029)
3.7.3 Latin America Glucokinase Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucokinase 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Glucokinase 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glucokinase Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glucokinase Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucokinase Sales by Type (2018-2029)
4.1.1 Global Glucokinase Sales by Type (2018-2023)
4.1.2 Global Glucokinase Sales by Type (2024-2029)
4.1.3 Global Glucokinase Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Glucokinase Revenue by Type (2018-2029)
4.2.1 Global Glucokinase Revenue by Type (2018-2023)
4.2.2 Global Glucokinase Revenue by Type (2024-2029)
4.2.3 Global Glucokinase Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Glucokinase Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glucokinase Sales by Application (2018-2029)
5.1.1 Global Glucokinase Sales by Application (2018-2023)
5.1.2 Global Glucokinase Sales by Application (2024-2029)
5.1.3 Global Glucokinase Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Glucokinase Revenue by Application (2018-2029)
5.2.1 Global Glucokinase Revenue by Application (2018-2023)
5.2.2 Global Glucokinase Revenue by Application (2024-2029)
5.2.3 Global Glucokinase Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Glucokinase Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen Inc
6.1.1 Amgen Inc Corporation Information
6.1.2 Amgen Inc Description and Business Overview
6.1.3 Amgen Inc Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen Inc Glucokinase Product Portfolio
6.1.5 Amgen Inc Recent Developments/Updates
6.2 Eli Lilly and Co
6.2.1 Eli Lilly and Co Corporation Information
6.2.2 Eli Lilly and Co Description and Business Overview
6.2.3 Eli Lilly and Co Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly and Co Glucokinase Product Portfolio
6.2.5 Eli Lilly and Co Recent Developments/Updates
6.3 Ligand Pharmaceuticals Inc
6.3.1 Ligand Pharmaceuticals Inc Corporation Information
6.3.2 Ligand Pharmaceuticals Inc Description and Business Overview
6.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
6.3.5 Ligand Pharmaceuticals Inc Recent Developments/Updates
6.4 Merck & Co Inc
6.4.1 Merck & Co Inc Corporation Information
6.4.2 Merck & Co Inc Description and Business Overview
6.4.3 Merck & Co Inc Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck & Co Inc Glucokinase Product Portfolio
6.4.5 Merck & Co Inc Recent Developments/Updates
6.5 Poxel SA
6.5.1 Poxel SA Corporation Information
6.5.2 Poxel SA Description and Business Overview
6.5.3 Poxel SA Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Poxel SA Glucokinase Product Portfolio
6.5.5 Poxel SA Recent Developments/Updates
6.6 Teijin Pharma Ltd
6.6.1 Teijin Pharma Ltd Corporation Information
6.6.2 Teijin Pharma Ltd Description and Business Overview
6.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
6.6.5 Teijin Pharma Ltd Recent Developments/Updates
6.7 vTv Therapeutics Inc
6.6.1 vTv Therapeutics Inc Corporation Information
6.6.2 vTv Therapeutics Inc Description and Business Overview
6.6.3 vTv Therapeutics Inc Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.4.4 vTv Therapeutics Inc Glucokinase Product Portfolio
6.7.5 vTv Therapeutics Inc Recent Developments/Updates
6.8 Yuhan Corp
6.8.1 Yuhan Corp Corporation Information
6.8.2 Yuhan Corp Description and Business Overview
6.8.3 Yuhan Corp Glucokinase Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yuhan Corp Glucokinase Product Portfolio
6.8.5 Yuhan Corp Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucokinase Industry Chain Analysis
7.2 Glucokinase Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucokinase Production Mode & Process
7.4 Glucokinase Sales and 麻豆原创ing
7.4.1 Glucokinase Sales Channels
7.4.2 Glucokinase Distributors
7.5 Glucokinase Customers
8 Glucokinase 麻豆原创 Dynamics
8.1 Glucokinase Industry Trends
8.2 Glucokinase 麻豆原创 Drivers
8.3 Glucokinase 麻豆原创 Challenges
8.4 Glucokinase 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.